Siyun Shen

1.5k total citations · 1 hit paper
13 papers, 546 citations indexed

About

Siyun Shen is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Siyun Shen has authored 13 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Siyun Shen's work include Cancer Immunotherapy and Biomarkers (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Siyun Shen is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Siyun Shen collaborates with scholars based in China, South Korea and Macao. Siyun Shen's co-authors include Lei Chen, Hongyang Wang, Rui Wu, Yanjing Zhu, Xinyao Qiu, Xuan Wu, Shan Wang, Shuai Yang, Kaiting Wang and Tong Wu and has published in prestigious journals such as Nature Communications, Cancer Research and Advanced Science.

In The Last Decade

Siyun Shen

13 papers receiving 542 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

M6A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma

2021 174 citations Xinyao Qiu, Shuai Yang et al. Cancer Research profile →

Peers

Siyun Shen

MB

ONCOL

CR

IMMUN

HEPAT

Kai Lei China

Zihao Dai China

G. Pasquini Italy

Ze-Qin Guo China

Xingwang Jia China

Eugenia R. Zanella Italy

Caroline Hego France

Carina Hage Switzerland

Sze Keong Tey Hong Kong

Mao Zhang China

Kai Lei China

Siyun Shen

274 ×0.9

MB

128 ×0.6

ONCOL

155 ×0.8

CR

90 ×0.6

IMMUN

81 ×1.2

HEPAT

Citations per year, relative to Siyun Shen Siyun Shen (= 1×) peers Kai Lei

Countries citing papers authored by Siyun Shen

Since Specialization

Citations

This map shows the geographic impact of Siyun Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siyun Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siyun Shen more than expected).

Fields of papers citing papers by Siyun Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siyun Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siyun Shen. The network helps show where Siyun Shen may publish in the future.

Co-authorship network of co-authors of Siyun Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Siyun Shen. A scholar is included among the top collaborators of Siyun Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siyun Shen. Siyun Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Zhang, Yangqianwen, Shuowu Liu, Zihan Zhao, et al.. (2025). PPP1R12B inhibits cell proliferation by inducing G0/G1 phase arrest via PAK2/β-catenin axis in hepatocellular carcinoma. Frontiers in Cell and Developmental Biology. 13. 1621705–1621705. 1 indexed citations

2.

Wu, Jianmin, Xiongfei Xu, Qingzheng Zhang, et al.. (2025). Cell-free DNA testing for the detection and prognosis prediction of pancreatic cancer. Nature Communications. 16(1). 6645–6645. 1 indexed citations

3.

Wang, Kaiting, Jianmin Wu, Yang Zhao, et al.. (2024). Hyperactivation of β-catenin signal in hepatocellular carcinoma recruits myeloid-derived suppressor cells through PF4-CXCR3 axis. Cancer Letters. 586. 216690–216690. 11 indexed citations

4.

Qiu, Xinyao, Tao Zhou, Shuai Li, et al.. (2024). Spatial single-cell protein landscape reveals vimentinhigh macrophages as immune-suppressive in the microenvironment of hepatocellular carcinoma. Nature Cancer. 5(10). 1557–1578. 23 indexed citations

5.

Wu, Jianmin, Xinyao Qiu, Siyun Shen, et al.. (2023). A Noninvasive Approach to Evaluate Tumor Immune Microenvironment and Predict Outcomes in Hepatocellular Carcinoma. PubMed. 3(6). 549–564. 38 indexed citations

6.

Wang, Wenwen, Xing Zheng, Jinxia Bao, et al.. (2022). Tumor-Specific CircRNA-Derived Antigen Peptide Identification for Hepatobiliary Tumors. Engineering. 22. 159–170. 5 indexed citations

7.

Wang, Wenwen, Yanjing Zhu, Jinxia Bao, et al.. (2022). Hepatobiliary Tumor Organoids Reveal HLA Class I Neoantigen Landscape and Antitumoral Activity of Neoantigen Peptide Enhanced with Immune Checkpoint Inhibitors. Advanced Science. 9(22). e2105810–e2105810. 45 indexed citations

8.

Qiu, Xinyao, Shuai Yang, Shan Wang, et al.. (2021). M6A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma. Cancer Research. 81(18). 4778–4793. 174 indexed citations breakdown →

9.

Zhao, Yan, Zhixuan Li, Yanjing Zhu, et al.. (2021). Single‐Cell Transcriptome Analysis Uncovers Intratumoral Heterogeneity and Underlying Mechanisms for Drug Resistance in Hepatobiliary Tumor Organoids. Advanced Science. 8(11). e2003897–e2003897. 93 indexed citations

10.

Wu, Tong, Yingcheng Yang, Bo Zheng, et al.. (2021). Distinct Immune Signatures in Peripheral Blood Predict Chemosensitivity in Intrahepatic Cholangiocarcinoma Patients. Engineering. 7(10). 1381–1392. 3 indexed citations

11.

Li, Zhixuan, Bo Zheng, Xinyao Qiu, et al.. (2020). The identification and functional analysis of CD8+PD-1+CD161+ T cells in hepatocellular carcinoma. npj Precision Oncology. 4(1). 28–28. 27 indexed citations

12.

Zheng, Bo, Dongfang Wang, Xinyao Qiu, et al.. (2020). Trajectory and Functional Analysis of PD‐1^high CD4⁺CD8⁺ T Cells in Hepatocellular Carcinoma by Single‐Cell Cytometry and Transcriptome Sequencing. Advanced Science. 7(13). 81 indexed citations

13.

Zhang, Shu, Yuming Liu, Jing Chen, et al.. (2020). Autoantibody signature in hepatocellular carcinoma using seromics. Journal of Hematology & Oncology. 13(1). 85–85. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact